Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment

Chimeric antigen receptor (CAR) immunotherapy is one of the most promising modern approaches for the treatment of cancer. To date only two CAR T-cell products, Kymriah(®) and Yescarta(®), have been approved by the Food and Drug Administration (FDA) for the treatment of lymphoblastic leukemia and B-c...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Titov, Aleksei, Valiullina, Aygul, Zmievskaya, Ekaterina, Zaikova, Ekaterina, Petukhov, Alexey, Miftakhova, Regina, Bulatov, Emil, Rizvanov, Albert
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016531/
https://ncbi.nlm.nih.gov/pubmed/31947775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010125
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items